NCT06262399View on ClinicalTrials.gov

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Enrolling by invitationOBSERVATIONAL
Enrollment

100

Participants

Timeline

Start Date

April 12, 2024

Primary Completion Date

April 30, 2040

Study Completion Date

April 30, 2040

Conditions
Hereditary Angioedema
Trial Locations (5)

Unknown

Centre National de Reference - Grenoble, Grenoble

Hôpital Claude Huriez, Lille

University of Amsterdam Academic Medical Center, Amsterdam

New Zealand Clinical Research, Auckland

Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Cambridge

Sponsors
All Listed Sponsors
lead

Intellia Therapeutics

INDUSTRY

NCT06262399 - Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002 | Biotech Hunter | Biotech Hunter